近期关于使用他法米地治疗后心脏摄取锝标记二磷酸二酯（Tc-DPD）的证据可能揭示ATTR淀粉样变性患者超早期诊断的途径。 - Suppr | 超能文献

Recent Evidence on Cardiac Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis.

作者信息

Caobelli Federico

出版信息

J Nucl Med. 2024 Feb 1;65(2):329. doi: 10.2967/jnumed.123.266676.

DOI:10.2967/jnumed.123.266676

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Recent Evidence on Cardiac Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis.近期关于使用他法米地治疗后心脏摄取锝标记二磷酸二酯（Tc-DPD）的证据可能揭示ATTR淀粉样变性患者超早期诊断的途径。

J Nucl Med. 2024 Feb 1;65(2):329. doi: 10.2967/jnumed.123.266676.

2

Reply: Recent Evidence on Cardiac Tc-DPD Uptake After Therapy with Tafamidis May Reveal the Road to an Ultra-Early Diagnosis in Patients with ATTR Amyloidosis.

J Nucl Med. 2024 Feb 1;65(2):330. doi: 10.2967/jnumed.123.266767.

3

Single-center analysis of cardiac amyloidosis using 99m Tc-HMDP imaging for diagnosis and evaluation after tafamidis treatment.使用99m Tc-HMDP成像对法米替尼治疗后心脏淀粉样变性进行诊断和评估的单中心分析。

Nucl Med Commun. 2025 Jan 1;46(1):38-46. doi: 10.1097/MNM.0000000000001922. Epub 2024 Oct 31.

4

Regression of Myocardial Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis.心肌 Tc-DPD 摄取在塔法米迪治疗心脏转甲状腺素淀粉样变性后的消退。

J Nucl Med. 2023 Jul;64(7):1083-1086. doi: 10.2967/jnumed.122.265352. Epub 2023 Jun 8.

5

Quantitation of Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis.检测转甲状腺素蛋白相关心脏淀粉样变性患者 Tc-DPD 摄取量。

Amyloid. 2018 Sep;25(3):203-210. doi: 10.1080/13506129.2018.1520087.

6

Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.用特立氟胺治疗转甲状腺素蛋白心脏淀粉样变患者后的 Tc-99m 焦磷酸盐心脏扫描随访。

Jpn J Radiol. 2023 Aug;41(8):882-888. doi: 10.1007/s11604-023-01403-4. Epub 2023 Mar 15.

7

Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.塔非酰胺：一种用于治疗野生型转甲状腺素蛋白淀粉样变性和遗传性转甲状腺素蛋白淀粉样变性心肌病的选择性转甲状腺素蛋白稳定剂。

Drugs Today (Barc). 2019 Dec;55(12):727-734. doi: 10.1358/dot.2019.55.12.3078389.

8

Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [Tc]Tc-DPD whole body scan: comparison with late (bone) phase imaging.通过早期（软组织）阶段的[锝-99m]Tc-DPD全身扫描诊断心脏转甲状腺素蛋白（ATTR）淀粉样变性：与晚期（骨骼）阶段成像的比较

Eur Radiol. 2022 May;32(5):3035-3044. doi: 10.1007/s00330-021-08420-9. Epub 2022 Jan 15.

9

Single-photon emission computed tomography/computed tomography quantification of Tc-99m pyrophosphate uptake to assess tafamidis treatment response in transthyretin cardiac amyloidosis.利用单光子发射计算机断层扫描/计算机断层扫描对99m锝焦磷酸盐摄取进行定量分析，以评估他氟米他在转甲状腺素蛋白心脏淀粉样变中的治疗反应。

J Nucl Cardiol. 2024 Dec;42:102056. doi: 10.1016/j.nuclcard.2024.102056. Epub 2024 Oct 9.

10

Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.(99m)Tc-DPD 闪烁显像在遗传性转甲状腺素蛋白相关心脏淀粉样变性的诊断和预后中的作用。

JACC Cardiovasc Imaging. 2011 Jun;4(6):659-70. doi: 10.1016/j.jcmg.2011.03.016.

引用本文的文献

1

Analysis and insights of cardiac amyloidosis: novel perception of rare diseases in cardiology.心脏淀粉样变性的分析与见解：心脏病学中罕见疾病的新认知

Am J Transl Res. 2024 Sep 15;16(9):4534-4548. doi: 10.62347/KXHZ6884. eCollection 2024.

2

Collection on molecular imaging in cardiac amyloidosis.心脏淀粉样变性的分子成像研究

Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2163-2164. doi: 10.1007/s00259-024-06739-1.